1,750,000 KRW
40
2.23%
Last update Dec 17, 3:00 PM KST
Main market
Day range
1,740,000
1,790,000
Previous close
1,790,000
Open
1,790,000
Access this stock data via API
Subscribe
Samsung Biologics Co., Ltd.
1,750,000.00
40K
2.23%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 4.5T 3.7T 3.0T 1.6T
Cost of revenue 2.3T 1.9T 1.5T 841.6B
Gross profit 2.3T 1.8T 1.5T 726.5B
Operating expense
Research & development 144.6B 81.6B 45.9B 954.2M
Selling general and admin 476.7B 303.5B 209.5B 102.1B
Other operating expenses 21.4B 40.1B 37.5B 9.8B
Operating income 1.3T 1.1T 983.6B 537.3B
Non operating interest income
Income 63.8B 95.7B 53.3B 9.7B
Expense 50.1B 81.6B 64.1B 14.7B
Other income expense
Pretax income 1.4T 1.1T 1.0T 561.3B
Tax provision 286.7B 262.3B 211.0B 167.7B
Net income 1.1T 857.7B 798.1B 393.6B
Basic EPS 15.2K 12.1K 11.4K 5.9K
Diluted EPS 15.2K 12.1K 11.4K 5.9K
Basic average shares 71.2M 71.2M 69.7M 66.9M
Diluted average shares 71.2M 71.2M 69.7M 66.9M
EBITDA 2.1T 1.7T 1.3T 740.7B
Net income from continuing op. 1.1T 857.7B 798.1B 393.6B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 16 minutes

12:13
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:30 - 09:00
Main market
09:00 - 15:30
Post-market
15:30 - 18:00
All times are displayed in the Asia/Seoul timezone (KST, UTC+09:00).